Famotidine versus pantoprazole

Am J Crit Care. 2008 Jul;17(4):311-2; author reply 312.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles / therapeutic use*
  • Critical Illness
  • Famotidine / therapeutic use*
  • Histamine H2 Antagonists / therapeutic use*
  • Humans
  • Pantoprazole
  • Peptic Ulcer Hemorrhage / etiology
  • Peptic Ulcer Hemorrhage / prevention & control*
  • Proton Pump Inhibitors / therapeutic use*
  • Respiration, Artificial / adverse effects

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Histamine H2 Antagonists
  • Proton Pump Inhibitors
  • Famotidine
  • Pantoprazole